Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
Plaintiff: Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and Allergan Pharmaceuticals International Limited
Defendant: Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Case Number: 1:2019cv01674
Filed: September 6, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on February 24, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
February 24, 2022 Filing 86 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,741,356 B2; 7,786,158 B2; 8,344,011 B2; 8,609,709 B2; 8,772,325 B2; 9,205,076 B2; 9,700,542 B2; 10,213,415 B2. (Attachments: #1 Amended Order)(nms)
February 24, 2022 Opinion or Order Filing 85 SO ORDERED Granting #84 Amended Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 2/24/2022. (nms)
February 24, 2022 Filing 84 AMENDED Stipulation of Dismissal, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Attachments: #1 Letter)(Tigan, Jeremy) Modified on 2/24/2022 (nms).
February 10, 2022 Filing 83 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2; 7,786,158 B2; 8,344,011 B2; 8,609,709 B2; 8,772,325 B2; 9,205,076 B2; 9,700,542 B2; 10,213,415 B2. (Attachments: #1 Order)(nms)
February 9, 2022 Opinion or Order Filing 82 SO ORDERED Granting #81 Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 2/9/2022. (nms)
February 9, 2022 Filing 81 STIPULATION of Dismissal by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
December 20, 2021 Pro Hac Vice Attorney Michael P. Hogan for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
December 6, 2021 Filing 80 NOTICE of Withdrawal of Kenneth L. Dorsney, Cortlan S. Hitch and Morris James LLP for Aurobindo by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth)
November 18, 2021 Filing 79 NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Myer, R.)
October 18, 2021 Filing 78 MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
October 18, 2021 Opinion or Order SO ORDERED, re #78 MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Richard G. Andrews on 10/18/2021. (nms)
August 30, 2021 Opinion or Order Filing 77 SO ORDERED Granting (D.I. 57 in 20-cv-1479-RGA; D.I. 76 in 19-cv-1674-RGA; D.I. 76 in 20-cv-1344-RGA) STIPULATION and Proposed Order to Extend Time (*Reset Deadlines/Hearings: Pretrial Order due by 10/11/2022, Status letter due by 7/6/2022, a Bench Trial is set to start 11/7/2022, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews, a Pretrial Conference is set for 10/21/2022, at 8:30 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:19-cv-01674-RGA, 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms)
August 27, 2021 Filing 76 STIPULATION and Proposed Order to Extend Time - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 8/30/2021 (nms). Modified on 8/30/2021 (nms).
August 16, 2021 Opinion or Order Filing 75 SO ORDERED Granting (D.I. 218 in 19-cv-1727-RGA; 74 in D.I. 19-cv-1674-RGA) Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 8/16/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
August 11, 2021 Filing 74 STIPULATION and [Proposed] Order by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy)
August 9, 2021 Opinion or Order Filing 73 SO ORDERED Granting #72 Stipulations Concerning Infringement of U.S. Patent Nos. 7,741,356; 7,786,158; 8,344,011; 8,609,709; 8,722,325; 9,205,542; 10,213,415. Signed by Judge Richard G. Andrews on 8/9/2021. (nms) (nms).
August 9, 2021 Filing 72 STIPULATION Concerning Infringement of U.S. Patent Nos. 7,741,356, 7,786,158, 8,344,011, 8,609,709, 8,772,325, 9,205,076, 9,700,542, 10,213,415 by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
June 28, 2021 Filing 71 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Admissions to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Nos. 1-16) and (2) Plaintiffs' Third Set of Interrogatories to Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. (Nos. 8-23) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
June 24, 2021 Filing 70 NOTICE OF SERVICE of Plaintiffs' First Supplemental Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
June 21, 2021 Filing 69 NOTICE OF SERVICE of Aurobindo's Responses and Objections to Plaintiffs' Notice of 30(b)(6) Deposition filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
June 16, 2021 Filing 68 NOTICE OF SERVICE of Aurobindo's Responses and Objections to Plaintiffs' Second Set of Interrogatories (No. 7) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
June 1, 2021 Filing 67 NOTICE OF SERVICE of (1) Plaintiffs' Notice of the Deposition of Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. Pursuant to Fed. R. Civ. 30(b)(6) and (2) Plaintiffs' Notice to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. of Depositions Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
May 17, 2021 Filing 66 NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (No. 7) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
April 14, 2021 Filing 65 NOTICE of Withdrawal of Counsel by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV (Tigan, Jeremy)
April 5, 2021 Opinion or Order Filing 64 SO ORDERED as modified re (D.I. 31 in 20-cv-1479-RGA; D.I. 36 in 20-cv-1344-RGA; D.I. 152 in 19-cv-1727-RGA) Stipulation and Proposed Order to Modify Case Schedules. Signed by Judge Richard G. Andrews on 4/5/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA, 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms)
April 5, 2021 Opinion or Order SO ORDERED, re #62 MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, Carolyn Wall, James Yi Li and Mark A. Hayden of O'Melveny & Myers LLP, filed by Janssen Pharmaceutica NV, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 4/5/2021. (nms)
April 2, 2021 Filing 63 NOTICE of Appearance of Lisa B. Pensabene of O'Melveny & Myers LLP by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV (Tigan, Jeremy)
April 2, 2021 Filing 62 MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, Carolyn Wall, James Yi Li and Mark A. Hayden of O'Melveny & Myers LLP - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
April 2, 2021 Filing 61 NOTICE requesting Clerk to remove Amanda K. Antons as co-counsel. Reason for request: No Longer with Firm. (Tigan, Jeremy)
March 31, 2021 Filing 60 STIPULATION and [Proposed] Order to Modify Case Schedules by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy)
March 29, 2021 Opinion or Order Filing 59 SO ORDERED Granting #58 PROPOSED Addendum to Stipulated Protective Order. Signed by Judge Richard G. Andrews on 3/29/2021. (nms)
March 29, 2021 Filing 58 [Proposed] Addendum to Stipulated Protective Order, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 3/29/2021 (nms).
January 14, 2021 Filing 57 NOTICE OF SERVICE of Aurobindo's First Set of Requests for Production to Plaintiffs (Nos. 1-51) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
January 13, 2021 Opinion or Order SO ORDERED, re (D.I. 56 in 19-cv-1674-RGA; D.I. 143 in 19-cv-1727-RGA) STIPULATION for Extension of Time between Plaintiffs and Aurobindo to substantially complete document production to January 19, 2021. Signed by Judge Richard G. Andrews on 1/13/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
January 12, 2021 Filing 56 STIPULATION for Extension of Time - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 1/13/2021 (nms).
January 12, 2021 Opinion or Order SO ORDERED, re (D.I. 55 in 19-cv-1674-RGA; D.I. 142 in 19-cv-1727-RGA) STIPULATION for Extension of Time for the substantial completion of document production to January 12, 2021. Signed by Judge Richard G. Andrews on 1/12/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
January 11, 2021 Filing 55 STIPULATION for Extension of Time for the substantial completion of document production to January 12, 2021 (between Plaintiffs and Aurobindo only) - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 1/12/2021 (nms).
January 11, 2021 Filing 54 NOTICE OF SERVICE of Aurobindo's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-6) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
November 30, 2020 Filing 53 NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Nos. 1-6) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
November 20, 2020 Opinion or Order SO ORDERED, re #52 STIPULATION TO EXTEND TIME to Substantially Complete Document Production to January 11, 2021. Signed by Judge Richard G. Andrews on 11/20/2020. (nms)
November 19, 2020 Filing 52 STIPULATION TO EXTEND TIME to Substantially Complete Document Production to January 11, 2021 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
September 18, 2020 Opinion or Order Filing 51 SO ORDERED Granting #50 Stipulation and Proposed Order Regarding Claim Construction and Markman Hearing. The December 21, 2020, Markman hearing scheduled is CANCELED. Signed by Judge Richard G. Andrews on 9/18/2020. (nms)
September 17, 2020 Filing 50 STIPULATION and [Proposed] Order Regarding Claim Construction and Markman Hearing by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
September 16, 2020 Filing 49 MOTION for Pro Hac Vice Appearance of Attorney Amanda K. Antons - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy)
September 16, 2020 Opinion or Order SO ORDERED, re (D.I. 111 in 19-cv-1727-RGA; D.I. 49 in 19-cv-1674-RGA)MOTION for Pro Hac Vice Appearance of Attorney Amanda K. Antons, filed by Janssen Pharmaceutica NV, Allergan Pharmaceuticals International Limited, Eden Biodesign, LLC., Allergan USA, Inc., Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 9/16/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
September 1, 2020 Opinion or Order Filing 48 STIPULATION and Order to Extend Time - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 9/1/2020 (nms).
September 1, 2020 Opinion or Order SO ORDERED, re #48 STIPULATION and Order to Extend Time (*answering claim construction brief due by 9/8/2020, reply claim construction brief due by 10/12/2020). Signed by Judge Richard G. Andrews on 9/1/2020. (nms)
August 24, 2020 Filing 47 NOTICE OF SERVICE of Aurobindo's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-64) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
August 5, 2020 Filing 46 NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
July 31, 2020 Opinion or Order Filing 45 SO ORDERED Granting #44 Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 7/31/2020. (nms)
July 31, 2020 Filing 44 PROPOSED Protective Order, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 7/31/2020 (nms).
July 23, 2020 CORRECTING ENTRY: The main document of the Joint Claim Construction Chart (D.I. #43 ) has been replaced at counsel's request to correct an error on the last page. (crb)
July 22, 2020 Filing 43 JOINT Claim Construction Chart, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Attachments: #1 Exhibits 1-4, #2 Exhibits 5-8, #3 Exhibits 9-16, #4 Exhibits A-Q)(Tigan, Jeremy) Modified on 7/23/2020 (nms). (Main Document 43 replaced on 7/23/2020) (crb).
July 20, 2020 Filing 42 STIPULATION TO EXTEND TIME to File Joint Claim Construction Chart to July 22, 2020 - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
July 20, 2020 Opinion or Order SO ORDERED, re (98 in 19-cv-1727-RGA; 42 in 19-cv-1674-RGA) Stipulation and Order to Extend Time. Signed by Judge Richard G. Andrews on 7/20/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
July 16, 2020 Filing 41 STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to July 31, 2020 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
July 16, 2020 Opinion or Order SO ORDERED, re #41 STIPULATION and Order to Extend time to submit proposed Protective Order to July 31, 2020. Signed by Judge Richard G. Andrews on 7/16/2020. (nms)
July 9, 2020 Filing 40 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things for Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Nos. 1-64) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
July 8, 2020 Filing 39 NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
June 29, 2020 Filing 38 NOTICE OF SERVICE of Aurobindo's Initial Invalidity Contentions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
June 22, 2020 Opinion or Order SO ORDERED, re #37 STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to July 17, 2020. Signed by Judge Richard G. Andrews on 6/22/2020. (nms)
June 19, 2020 Filing 37 STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to July 17, 2020 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
June 5, 2020 Opinion or Order Filing 36 STIPULATION and Order to Extend Time to submit Proposed Protective Order to June 19, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 6/5/2020 (nms).
June 5, 2020 Opinion or Order SO ORDERED, re (36 in 19-cv-1674-RGA; 88 in 19-cv-01727-RGA) STIPULATION and Order to Extend Time to submit Proposeed Protective Order to June 19, 2020. Signed by Judge Richard G. Andrews on 6/5/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
May 26, 2020 Filing 35 NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
May 22, 2020 Filing 34 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to June 5, 2020 - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy)
May 22, 2020 Opinion or Order SO ORDERED, re (86 in 19-cv-1727-RGA; 34 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to June 5, 2020. Signed by Judge Richard G. Andrews on 5/22/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
May 15, 2020 Filing 33 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc. filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc.. (Blumenfeld, Jack)
May 11, 2020 Filing 32 STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to May 22, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy)
May 11, 2020 Opinion or Order SO ORDERED, re (32 in 19-cv-1674-RGA; 84 in 19-cv-1727-RGA) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to May 22, 2020. Signed by Judge Richard G. Andrews on 5/11/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
May 8, 2020 Pro Hac Vice Attorneys George J. Barry, III and Timothy H. Kratz for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
May 6, 2020 Opinion or Order SO ORDERED, re #31 MOTION for Pro Hac Vice Appearance of George J. Barry III and Attorney Timothy H. Kratz, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Richard G. Andrews on 5/6/2020. (nms)
May 5, 2020 Filing 31 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
April 27, 2020 Opinion or Order SO ORDERED, re (30 in 19-cv-1674-RGA; 81 in 19-cv-1727-RGA) STIPULATION and Order to Extend Time. Signed by Judge Richard G. Andrews on 4/27/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
April 24, 2020 Opinion or Order Filing 30 STIPULATION and Order to Extend Time - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 4/27/2020 (nms).
April 13, 2020 Opinion or Order SO ORDERED, re (79 in 19-cv-1727-RGA; 29 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to submit a proposed protective order to May 11, 2020. Signed by Judge Richard G. Andrews on 4/13/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
April 10, 2020 Filing 29 STIPULATION TO EXTEND TIME to submit a proposed protective order to May 11, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy)
March 27, 2020 Filing 28 NOTICE of Withdrawal of Counsel Jeffrey J. Lyons, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Lyons, Jeffrey) Modified on 3/27/2020 (nms).
March 20, 2020 Filing 27 NOTICE OF SERVICE of Aurobindo's Core Technical Documents filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
March 19, 2020 Filing 26 NOTICE requesting Clerk to remove Sky C. Adams of Quinn Emanuel Urquhart & Sullivan, LLP as co-counsel. Reason for request: No Longer with Firm. (Tigan, Jeremy)
March 12, 2020 Opinion or Order SO ORDERED, re (25 in 19-cv-1674-RGA; 70 in 19-cv-1727-RGA) STIPULATION and Order to Extend Time. Signed by Judge Richard G. Andrews on 3/11/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
March 11, 2020 Opinion or Order Filing 25 STIPULATION and Order to Extend Time - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Lyons, Jeffrey) Modified on 3/12/2020 (nms).
February 27, 2020 Opinion or Order SO ORDERED, re (65 in 19-cv-1727-RGA; 24 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to submit a proposed protective order to March 11, 2020. Signed by Judge Richard G. Andrews on 2/27/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
February 26, 2020 Filing 24 STIPULATION TO EXTEND TIME to submit a proposed protective order to March 11, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy)
February 14, 2020 Filing 23 NOTICE OF SERVICE of Plaintiffs' Initial Paragraph 4(a) Disclosures filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
February 14, 2020 Filing 22 NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
February 14, 2020 Filing 21 NOTICE OF SERVICE of Aurobindo's Paragraph 3 Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
February 13, 2020 Opinion or Order SO ORDERED, re (57 in 19-cv-1727-RGA; 20 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to submit a proposed protective order to February 26, 2020. Signed by Judge Richard G. Andrews on 2/13/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
February 12, 2020 Filing 20 STIPULATION TO EXTEND TIME to submit a proposed protective order to February 26, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy)
February 10, 2020 Opinion or Order SO ORDERED, re (56 in 19-cv-1727-RGA; 19 in 19-cv-1674-RGA) STIPULATION and Order to Extend Time. Signed by Judge Richard G. Andrews on 2/10/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms)
February 7, 2020 Opinion or Order Filing 19 STIPULATION and Order for Extension of Time - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 2/10/2020 (nms).
February 3, 2020 Opinion or Order Filing 18 ORAL ORDER Setting Teleconference: Defense counsel to initiate the call. A Telephone Conference is set for 2/8/2021 at 9:00 AM Eastern Time with Judge Mary Pat Thynge. Plaintiffs' counsel shall forward a copy of the claim construction decision when issued which may be forwarded by email, with a copy to Ms. Kennedy, my Judicial Administrator. In the interim, should either side wish to discuss this matter with me, counsel/parties are encouraged to communicate with me via Ms. Kennedy to schedule a confidential (no required notice to opposing counsel) private teleconference. Ordered by Judge Mary Pat Thynge on 2/3/20. (cak)
January 28, 2020 Filing 17 NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy)
January 28, 2020 Filing 16 NOTICE OF SERVICE of Aurobindo's Rule 26(a)(1) Initial Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
January 13, 2020 Opinion or Order Filing 15 ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 2/3/2020 at 11:00 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 1/13/20. (cak)
January 13, 2020 Opinion or Order Filing 14 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Fact Discovery completed by 5/14/2021. A Status Conference is set for 1/7/2022, at 9:00 AM. Joint Claim Construction Brief due by 11/23/2020. A Markman Hearing is set for 12/21/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 4/15/2022, at 9:00 AM in Courtroom 6A. A Bench Trial is set for 5/2/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 1/10/2020. (nms)
January 13, 2020 CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak)
January 10, 2020 Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 1/10/2020. Local counsel present for plaintiffs: J. Tigan. Local counsel present for defendants: K. Dorsney, P. Kraman, D. Gattuso, D. Bilson, S. Stamoulis. (Court Reporter Heather Triozzi.) (crb)
January 8, 2020 Filing 13 Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding Proposed Scheduling Orders. (Attachments: #1 Exhibits A-B)(Blumenfeld, Jack)
January 6, 2020 Opinion or Order SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Sky C. Adams and Allyson E. Parks, filed by Janssen Pharmaceutica NV, Eden Biodesign, LLC., Allergan USA, Inc., Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 1/6/2020. (nms)
January 3, 2020 Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Sky C. Adams and Allyson E. Parks - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Janssen Pharmaceutica NV. (Tigan, Jeremy)
December 12, 2019 Opinion or Order Filing 11 Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 1/10/2020, at 11:45 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 12/12/2019. (nms)
December 2, 2019 Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
December 2, 2019 Filing 9 ANSWER to #1 Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
September 30, 2019 Filing 8 STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. to answer, move or otherwise respond to the Complaint to December 2, 2019 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
September 30, 2019 Opinion or Order SO ORDERED, re #8 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to December 2, 2019 (*Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 12/2/2019; Aurobindo Pharma USA, Inc. answer due 12/2/2019). Signed by Judge Richard G. Andrews on 9/30/2019. (nms)
September 12, 2019 Filing 7 WAIVER OF SERVICE returned executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV: For Aurobindo Pharma Ltd. waiver sent on 9/12/2019, answer due 11/12/2019. (Blumenfeld, Jack)
September 11, 2019 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
September 9, 2019 Filing 6 SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. Aurobindo Pharma USA, Inc. served on 9/9/2019, answer due 9/30/2019. (Blumenfeld, Jack)
September 9, 2019 Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 9/9/2019; Aurobindo Pharma USA, Inc. on 9/9/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (myr)
September 6, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV; Corporate Parent Allergan plc for Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc. filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (myr)
September 6, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (myr)
September 6, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or after 7/31/2019. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: On or after 11/27/2022. (myr)
September 6, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
September 6, 2019 Filing 1 COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2725571.) - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Attachments: #1 Exhibit A-H, #2 Civil Cover Sheet)(myr)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Allergan USA, Inc.
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Represented By: Jeffrey J. Lyons
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Janssen Pharmaceutica NV
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Represented By: Jeffrey J. Lyons
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Allergan Holdings Unlimited Company
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Represented By: Jeffrey J. Lyons
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Allergan Pharmaceuticals International Limited
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Represented By: Jeffrey J. Lyons
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma USA, Inc.
Represented By: Kenneth Laurence Dorsney
Represented By: George J. Barry, III
Represented By: Timothy H. Kratz
Represented By: R. Touhey Myer
Represented By: Michael P. Hogan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma Ltd.
Represented By: Kenneth Laurence Dorsney
Represented By: George J. Barry, III
Represented By: Timothy H. Kratz
Represented By: R. Touhey Myer
Represented By: Michael P. Hogan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?